1. OP0174 Alteration of mediators of vascular inflammation by anifrolumab in the phase iib muse study in sle. (12th June 2018) Authors: White, W.I.; Seto, N.L.; Playford, M.P.; Casey, K.A.; Smith, M.A.; Carlucci, P.; Yu, B.; Wang, L.; Illei, G.; Mehta, N.; Kaplan, M.J. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗